pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
the cabinet

Drugs

8,127 products tracked · 1,831 matching

★ save view↓export CSV
phase
allMarketedPhase 3Phase 2Phase 1Preclinical
sort
catalystsrecentname
therapeutic area
allOncology1831Infectious Disease718Cardiology425Pulmonology396Immunology371Ophthalmology368Dermatology300Women's Health
viewlistcards
Phase 2
Stenoparib
Epithelial Ovarian Cancer
Tankyrase 1/2Poly [ADP-ribose] polymerase 2
$ALLRAllarity Therapeutics, Inc.
0 catalysts
Phase 2
SurVaxM
Glioblastoma Multiforme (GBM)
Baculoviral IAP repeat-containing protein 5Hemocyanin 1
MimiVax LLC
0 catalysts
Marketed
← prev
page 35 of 62
next →
131
Pain89
Neurology1
Sylatron
Sylatron (peginterferon alfa-2b)
Melanoma
$MRKMerck & Co., Inc.
0 catalysts
Phase 1
SynKIR-110
Bile Duct Cancer (Cholangiocarcinoma)
Verismo Therapeutics Inc
0 catalysts
Phase 1
SynKIR-310
Diffuse Large B-Cell Lymphoma
Verismo Therapeutics Inc
0 catalysts
Phase 1
T-1101
Neuroendocrine Tumors
Taivex Therapeutics Inc
0 catalysts
Preclinical
T-Cell Therapy
Solid Tumor
Eureka Therapeutics Inc
0 catalysts
Phase 2
TARA-002
Unspecified Rare Disease
$TARAProtara Therapeutics, Inc.
0 catalysts
Phase 2
TAS-0728
Solid Tumor
Taiho Pharmaceutical Co Ltd
0 catalysts
Phase 1
TAS-2940
Solid Tumor
Taiho Oncology Inc
0 catalysts
Phase 1
TAVO-412
Gastric Cancer
Tavotek Biotherapeutics
0 catalysts
Preclinical
TB-511
Hepatocellular Carcinoma
Twinpigbiolab Co Ltd
0 catalysts
Preclinical
TC-220
Breast Cancer
TAE Life Sciences LLC
0 catalysts
Phase 1
TEB-17231
Solid Tumor
280Bio Inc
0 catalysts
Phase 2
TERN-701
Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia)
$TERNTerns Pharmaceuticals, Inc.
0 catalysts
Phase 2
TG-01
Pancreatic Cancer
Prostaglandin G/H synthase 2
Circio Holding ASA
0 catalysts
Phase 2
TG-1042
Basal Cell Carcinoma (Basal Cell Epithelioma)
Stamford Pharmaceuticals Inc
0 catalysts
Phase 2
TG-4050
Myvac
Head And Neck Cancer
Transgene SA
0 catalysts
Phase 1
TGI-2
Metastatic Colorectal Cancer
Hefei TG ImmunoPharma Co Ltd
0 catalysts
Phase 1
TGNS-11
Head And Neck Squamous Cell Carcinoma (HNSC)
Toragen Inc
0 catalysts
Phase 1
TGW-101
Castration-Resistant Prostate Cancer (CRPC)
Tagworks Pharmaceuticals BV
0 catalysts
Preclinical
TH-1904
Ovarian Cancer
Theratechnologies Inc
0 catalysts
Preclinical
TH-1940
Solid Tumor
$CNTNCanton Strategic Holdings, Inc.
0 catalysts
Preclinical
TH-3215
Solid Tumor
$CNTNCanton Strategic Holdings, Inc.
0 catalysts
Phase 2
TILT-123
Ovarian Cancer
TILT Biotherapeutics Ltd
0 catalysts
Preclinical
TJ-106
Breast Cancer
Phrontline Biopharma Co Ltd
0 catalysts
Phase 2
TLD-1433
Non Muscle Invasive Bladder Cancer (NMIBC) (Superficial Bladder Cancer)
Theralase Technologies Inc
0 catalysts
Phase 1
TLX-090
Cyclosam
Bone Metastasis
$TLXTelix Pharmaceuticals Ltd
0 catalysts
Preclinical
TLX-102
Malignant Glioma
$TLXTelix Pharmaceuticals Ltd
0 catalysts
Phase 2
TLX-250
Metastatic Renal Cell Carcinoma
$TLXTelix Pharmaceuticals Ltd
0 catalysts